financing costs - (3,142)
Lease financing obligation proceeds - 15,113
Equity contribution from parent - 5,999
Payments of notes payable and long-term debt (3,443) (3,188)
Payments on obligations under capital leases (5,376) (3,989)
Net cash provided by (used in)
financing activities (8,819) 10,793
Net increase (decrease) in cash and cash
equivalents 13,407 (15,434)
Cash and cash equivalents, beginning of period 19,843 33,250
Cash and cash equivalents, end of period $33,250 $17,816
Schedule 5
Selected Operating Statistics
Three months Three months
ended December 31, ended December 31,
2006 2007
Number of hospitals within hospitals
(end of period) 12 9
Number of freestanding hospitals
(end of period) 8 10
Number of total hospitals (end of
period) 20 19
Licensed beds (end of period) 926 1,009
Average licensed beds (1) 905 1,009
Admissions 2,099 2,131
Patient days 56,410 57,437
Occupancy rate 67.8% 61.9%
Percent net patient service revenue
from Medicare 72.1% 64.0%
Percent net patient service revenue
from commercial payors and
Medicaid (2)
'/>"/>
SOURCE LifeCare Holdings, Inc. Copyright©2008 PR Newswire. All rights reserved | |
Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 Related medicine news :1.
LifeCare Hospitals of Wisconsin Unveils Center for Advanced Wound Healing2.
LifeCare Holdings, Inc. Announces Third Quarter Results3.
Batesville Holdings, Inc., Appoints Doug Wilson Senior Vice President Human Resources4.
Previously Disclosed Changes in Board Composition of NightHawk Radiology Holdings, Inc. Prompt Notice of Noncompliance from the Nasdaq Global Market5.
Solera Holdings, Inc. Appoints Jason Brady as General Counsel6.
Duane Reade Holdings, Inc. to Report Fourth Quarter and Full Year 2007 Financial Results7.
Whitemark Homes Signs Letter of Intent to Acquire Metiscan Holdings, Inc.8.
Vallon Holdings, LLC Launches New Subsidiary Focused on Contract Resources for the Minneapolis-St. Paul Life Science Industry9.
NightHawk Radiology Holdings, Inc. Announces Board Member Departure10.
NightHawk Radiology Holdings, Inc. to Speak at the Cowen and Company 28th Annual Health Care Conference on March 18, 200811.
Lixte Biotechnology Holdings, Inc. Announces Further Developments Regarding the Anti-Cancer Activity of Its Patent-Pending Proprietary Compounds